Aesthetic & Medical Excellence
News & Announcements
Updates, regulatory approvals and events from AME.
AME took part as a partner in the 9th Bahrain Dermatology, Laser and Aesthetics Conference & Exhibition (BDLA), held on 8–10 October 2026 in the Kingdom of Bahrain, and hosted the AME Industry Symposium on its opening day.
AME is proud to partner with REACH 26 in advancing medical education and shaping the future of regenerative medicine.
AME Company is pleased to participate in Teoxane Academy Turkey 2026, bringing together leading aesthetic medicine professionals for advanced scientific education, clinical knowledge exchange, and hands-on learning.
AME Company for Medical Devices is proud to host the Teoxane Academy in Saudi Arabia.
A correction to previously announced income statement figures for the period ending 30-06-2022.
AME Company announces its interim financial results for the first half of 2022.
The Extraordinary General Assembly held on 15 June 2022 approved the 2021 financial statements, a cash dividend of SAR 1.75 per share, and amendments to the company's bylaws.
AME Company announces SFDA approval for a DEKA medical laser product.
AME Company announces SFDA approval for Teoxane dermal filler products.
AME is proud to be an Elite Sponsor of SAAM 2026, the 5th Scientific Academy of Aesthetic Medicine Conference & Exhibition, on 5–7 November 2026 at the Fairmont Hotel, Riyadh, where the AME MedEd team will lead eight sessions.
